RxDoctor Payments Data

Diane Highum

Psychiatry · Costa Mesa, CANPI 1396868386

Payments from drug & device makers

What this record shows

That places this record below the midpoint for psychiatry clinicians in CA, where the typical reported total is $186.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$8,781,376in research payments, 2019–2025

Across 1,102 payments — averaging $7968.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Otsuka Pharmaceutical Development & Commercialization, Inc.$2.2M
  • AbbVie$1.8M
  • Teva Pharmaceuticals USA, Inc.$1.2M
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1.1M
  • Hoffmann-la Roche Limited$630K
  • Merck$542K
  • plus $1.3M from 16 others

How this compares

$0 in reported general payments places this provider in the 10th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California →

Other psychiatry in Costa Mesa

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →